Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Chin Med J (Engl). 2023 Oct 20;136(20):2476-2483. doi: 10.1097/CM9.0000000000002694. Epub 2023 May 17.
Several studies have reported that polygenic risk scores (PRSs) can enhance risk prediction of coronary artery disease (CAD) in European populations. However, research on this topic is far from sufficient in non-European countries, including China. We aimed to evaluate the potential of PRS for predicting CAD for primary prevention in the Chinese population.
Participants with genome-wide genotypic data from the China Kadoorie Biobank were divided into training ( n = 28,490) and testing sets ( n = 72,150). Ten previously developed PRSs were evaluated, and new ones were developed using clumping and thresholding or LDpred method. The PRS showing the strongest association with CAD in the training set was selected to further evaluate its effects on improving the traditional CAD risk-prediction model in the testing set. Genetic risk was computed by summing the product of the weights and allele dosages across genome-wide single-nucleotide polymorphisms. Prediction of the 10-year first CAD events was assessed using hazard ratios (HRs) and measures of model discrimination, calibration, and net reclassification improvement (NRI). Hard CAD (nonfatal I21-I23 and fatal I20-I25) and soft CAD (all fatal or nonfatal I20-I25) were analyzed separately.
In the testing set, 1214 hard and 7201 soft CAD cases were documented during a mean follow-up of 11.2 years. The HR per standard deviation of the optimal PRS was 1.26 (95% CI:1.19-1.33) for hard CAD. Based on a traditional CAD risk prediction model containing only non-laboratory-based information, the addition of PRS for hard CAD increased Harrell's C index by 0.001 (-0.001 to 0.003) in women and 0.003 (0.001 to 0.005) in men. Among the different high-risk thresholds ranging from 1% to 10%, the highest categorical NRI was 3.2% (95% CI: 0.4-6.0%) at a high-risk threshold of 10.0% in women. The association of the PRS with soft CAD was much weaker than with hard CAD, leading to minimal or no improvement in the soft CAD model.
In this Chinese population sample, the current PRSs minimally changed risk discrimination and offered little improvement in risk stratification for soft CAD. Therefore, this may not be suitable for promoting genetic screening in the general Chinese population to improve CAD risk prediction.
多项研究报告称,多基因风险评分(PRS)可增强欧洲人群冠心病(CAD)的风险预测。然而,包括中国在内的非欧洲国家对此类研究还远远不够。我们旨在评估 PRS 在中国人群中进行 CAD 一级预防的潜在价值。
从中国科赫里生物银行中获取全基因组基因型数据的参与者被分为训练集(n=28490)和测试集(n=72150)。评估了十种先前开发的 PRS,并使用聚类和阈值或 LDpred 方法开发了新的 PRS。在训练集中与 CAD 关联最强的 PRS 被选择进一步评估其在测试集中对改进传统 CAD 风险预测模型的影响。通过累加全基因组单核苷酸多态性的权重和等位基因剂量来计算遗传风险。使用危险比(HRs)和模型区分度、校准度和净重新分类改善(NRI)等指标评估了 10 年首次 CAD 事件的预测。分别分析了硬 CAD(非致命 I21-I23 和致命 I20-I25)和软 CAD(所有致命或非致命 I20-I25)。
在测试集中,1214 例硬 CAD 和 7201 例软 CAD 病例在平均 11.2 年的随访中记录。最优 PRS 的每个标准差的 HR 为 1.26(95%CI:1.19-1.33)用于硬 CAD。基于仅包含非实验室信息的传统 CAD 风险预测模型,硬 CAD 的 PRS 增加了 Harrell 的 C 指数 0.001(-0.001 至 0.003)在女性中,增加了 0.003(0.001 至 0.005)在男性中。在 1%至 10%的不同高危阈值范围内,在女性高危阈值为 10.0%时,最高分类 NRI 为 3.2%(95%CI:0.4-6.0%)。PRS 与软 CAD 的关联远弱于与硬 CAD 的关联,导致软 CAD 模型的风险分层几乎没有改善或没有改善。
在本中国人群样本中,当前的 PRS 对风险区分的影响很小,对软 CAD 的风险分层几乎没有改善。因此,这可能不适合在中国一般人群中推广基因筛查,以改善 CAD 风险预测。